An overview of nosocomial infections, including the role of the microbiology laboratory.

Clinical Microbiology Reviews
T G Emori, R P Gaynes

Abstract

An estimated 2 million patients develop nosocomial infections in the United States annually. The increasing number of antimicrobial agent-resistant pathogens and high-risk patients in hospitals are challenges to progress in preventing and controlling these infections. While Escherichia coli and Staphylococcus aureus remain the most common pathogens isolated overall from nosocomial infections, coagulase-negative staphylococci (CoNS), organisms previously considered contaminants in most cultures, are now the predominant pathogens in bloodstream infections. The growing number of antimicrobial agent-resistant organisms is troublesome, particularly vancomycin-resistant CoNS and Enterococcus spp. and Pseudomonas aeruginosa resistant to imipenem. The active involvement and cooperation of the microbiology laboratory are important to the infection control program, particularly in surveillance and the use of laboratory services for epidemiologic purposes. Surveillance is used to identify possible infection problems, monitor infection trends, and assess the quality of care in the hospital. It requires high-quality laboratory data that are timely and easily accessible.

References

Oct 5, 1978·The New England Journal of Medicine·M Finland
Aug 27, 1977·Lancet·M W CasewellI Phillips
Jun 9, 1977·The New England Journal of Medicine·D G MakiH W Sarafin
Feb 1, 1978·American Journal of Clinical Pathology·R A Weinstein, G F Mallison
Aug 1, 1977·Journal of Clinical Pathology·E T Houang, D Greenwood
May 26, 1978·Science·A Donabedian
Apr 1, 1979·Annals of Internal Medicine·T C Eickhoff
Feb 1, 1977·Antimicrobial Agents and Chemotherapy·R P Rennie, I B Duncan
Nov 1, 1975·Annals of Internal Medicine·A C Steere, G F Mallison
Mar 11, 1976·American Journal of Epidemiology·R P WenzelJ M Gwaltney
Sep 9, 1992·JAMA : the Journal of the American Medical Association·C Beck-SaguéW R Jarvis
Aug 1, 1992·American Journal of Infection Control·T H Holtz, R P Wenzel
Feb 1, 1991·American Journal of Infection Control·T G EmoriR P Gaynes
Sep 19, 1991·The New England Journal of Medicine·A S Relman
Sep 16, 1991·The American Journal of Medicine·R A GaribaldiT Lerer
Sep 16, 1991·The American Journal of Medicine·P A Gross
Sep 16, 1991·The American Journal of Medicine·R A Weinstein
Sep 16, 1991·The American Journal of Medicine·R P WenzelM A Pfaller
Sep 16, 1991·The American Journal of Medicine·R P Wenzel, M A Pfaller
Sep 16, 1991·The American Journal of Medicine·D E CravenT W Barber
Sep 16, 1991·The American Journal of Medicine·D R SchabergR P Gaynes
Sep 1, 1990·Journal of Clinical Microbiology·P R Hunter
Aug 1, 1989·Antimicrobial Agents and Chemotherapy·J TriasH Nikaido
Dec 1, 1989·The Journal of Infectious Diseases·S J GriffithR A Weinstein
Aug 1, 1989·Antimicrobial Agents and Chemotherapy·A PhilipponG Jacoby
Oct 1, 1989·American Journal of Infection Control·C H Patterson
Jun 1, 1988·American Journal of Infection Control·J S GarnerJ M Hughes
Sep 1, 1986·The Journal of Hospital Infection·D A Goldmann
Feb 1, 1988·The Journal of Hospital Infection·S Sutherland
Jul 21, 1988·The New England Journal of Medicine·R LeclercqP Courvalin
Jul 1, 1988·Reviews of Infectious Diseases·W E Sanders, C C Sanders
Aug 1, 1986·The Journal of Infectious Diseases·J P QuinnS A Lerner

❮ Previous
Next ❯

Citations

Nov 14, 1997·American Journal of Respiratory and Critical Care Medicine·M J BontenW A Buurman
Feb 6, 1998·FEMS Microbiology Reviews·E S Stanislavsky, J S Lam
Dec 1, 1998·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·M PujolF Gudiol
Jul 2, 1999·Letters in Applied Microbiology·L SeldinM C de Freire Bastos
Jan 5, 2000·FEMS Immunology and Medical Microbiology·R G Ulrich
Oct 6, 1999·American Journal of Respiratory and Critical Care Medicine·M J BontenE E Stobberingh
Sep 6, 2001·Diseases of the Colon and Rectum·J MiranskyJ G Guillem
Feb 17, 2001·Phytotherapy Research : PTR·H X Xu, S F Lee
May 31, 2001·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·W A Rutala, D J Weber
Apr 26, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·D E LowR N Jones
Jun 29, 2001·Infection Control and Hospital Epidemiology : the Official Journal of the Society of Hospital Epidemiologists of America·T A WichelhausV Brade
Jun 18, 2002·AORN Journal·Inge KjønniksenLeidulf Segadal
Jan 22, 2003·Environmental Microbiology·Jean-Paul PirnayMartin Zizi
Feb 8, 2003·Surgical Infections·Philip S Barie
Jul 26, 2003·The Journal of Biological Chemistry·Raquel García-CastellanosF Xavier Gomis-Ruth
Dec 23, 2003·Infection and Immunity·Miguel ReguéJuan M Tomás
Jul 20, 2005·Der Chirurg; Zeitschrift für alle Gebiete der operativen Medizen·S MaierC-D Heidecke
Nov 2, 2006·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·Astrid C S SobkeMathias Herrmann
Jun 30, 2007·Foodborne Pathogens and Disease·James L SmithNereus W Gunther
May 6, 2008·The Journal of Immunology : Official Journal of the American Association of Immunologists·Xiao SuMichael A Matthay
Jun 1, 2006·Journal of Applied Oral Science : Revista FOB·Alexandre Daher Yunes SalgadoOlívia Morais de Lima Mota
Oct 13, 2009·International Anesthesiology Clinics·Ursula A GalwayRaymond G Borkowski
Jul 20, 2010·Transplant Infectious Disease : an Official Journal of the Transplantation Society·M MikulskaC Viscoli
Oct 1, 2010·Worldviews on Evidence-based Nursing·Jenny JakobssonChristine Wann-Hansson
Sep 9, 2010·Biological & Pharmaceutical Bulletin·Yaya RukayadiJae-Kwan Hwang

❮ Previous
Next ❯

Related Concepts

Related Feeds

Allergy & Infectious Diseases (ASM)

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Allergy & Infectious Diseases

Allergies result from the hyperreactivity of the immune system to some environmental substance and can be life-threatening. Infectious diseases are caused by organisms including bacteria, viruses, fungi and parasites. They can be transmitted different ways, such as person-to-person. Here is the latest research on allergy and infectious diseases.

Antimicrobial Resistance (ASM)

Antimicrobial resistance poses a significant threat to the continued successful use of antimicrobial agents for the treatment of bacterial infections.

Carbapenems (ASM)

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.

Carbapenems

Carbapenems are members of the beta lactam class of antibiotics and are used for the treatment of severe or high-risk bacterial infections. Discover the latest research on carbapenems here.